ConductScience.org, home

Library / Trial comparisons

HPV Self Testing vs HPV at Health Centers: Acceptability

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.8580.8450.87wilsonClinicalTrials.gov
Risk in group 2000.00129wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.8580.8450.87newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 2loga group has no participants with the outcomeClinicalTrials.gov
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zeroClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on HPV Self Testing than on HPV at Health Centers1.171.151.18from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1HPV Self Testing
HPV self testing offered by CHWs during home visits~HPV self testing: Community Health Workers instructed women about cervical cancer and HPV testing, advised them on how to seek screening at health centers, and offered them the option of self-testing, providing women with educational materials on how to perform it.
2,6163,049OG000ClinicalTrials.gov
Group 2HPV at Health CentersCommunity Health Workers instructed women about cervical cancer and HPV testing and advised them on how to seek screening at health centers.02,964OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleAcceptabilityClinicalTrials.gov
Description
Defined as the proportion of women from the intervention group who were offered self-testing and accepted, as documented in the questionnaire, independently of if they ended up with a test in the information system.
ClinicalTrials.gov
Time framewithin 6 monthsClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleEvaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening UptakeClinicalTrials.gov
NCT numberNCT02095561ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsCervical Intraepithelial NeoplasiaClinicalTrials.gov
InterventionsHPV self testingClinicalTrials.gov
Lead sponsorInstituto Nacional del Cáncer, ArgentinaClinicalTrials.gov
Results first posted2014-04-29ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02095561?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.